One of the test patients died of a stroke. If it had anything to do with Androxal(R) then this is horrible news. Here is the quote from the RPRX press release...
"A third subject, treated with 12.5 mg of Androxal(R), with multiple risk factors for stroke, including untreated atrial fibrillation, diabetes, obesity and hyperlipidemia, suffered a fatal ischemic stroke."
Since NQ has failed to complete an audit and file an annual report how soon until they are delisted? Filing an annual report and audit is required to stay listed on the stock exchange.
Agreed that for some reason the buyers today must see the CFO quitting as positive. But, in my experience the exact opposite is usually true. Too many other warning signs are flashing on this stock. Time will bear out the real value which could be $0 if this company turns out to be a fraud.
Too many negative coincidences for me to not believe there is likely fraud here. Just because there are many stock buyers of NQ today betting on a happy outcome like a acquisition doesn't mean it will happen. My bet is over the long term the stock will continue to drift lower and then will really plunge when it is delisted from the NYSE and goes to OTC / pink sheets.
CFO quitting is very bad news for NQ. Eventually the truth will come out and the financial fraud will cause NQ to be de-listed. NQ may be going to the OTC market soon.
Wow! I am very surprised that NQ stock is up today. Their CFO quits and this is good news? Another fishy coincidence after their auditor quit? Where there is smoke there is usually fire. I am a seller of NQ at these prices. But, maybe I am crazy because for some reason NQ stock is up today. Unbelievable!
It has been a great run. Time to move on and take profits. TRUE is a just too richly valued even for a high growth stock in my opinion. It could run much higher, but the risks are just too great at these price levels. Time to move on. Plenty of other stocks out there I can switch to with more growth potential and lower prices. Thanks TRUE for a great ride...
Maybe but that news is several days old. Why would that stock not have jumped back on Friday or Monday? The move up today is still a mystery....
There must be some kind of rumor sending TRUE higher. Today's huge move to new highs needs to be back up by some new information soon... Or it could drop right back down. Does anyone have any news that would justify this big jump? Or is it just day traders playing with the stock?
MFLX missed on revenues, missed on earnings and missed on their next quarter guidance. Nothing good about this earnings report at all. Look for MFLX to drop big tomorrow and establish new 52 week lows.
PEIX is falling fast in after hours. Earnings must be out and not be good.
I was spot on with my call yesterday. Those who sold at $9 a share after hours last night made out very well today
Still doesn't have FDA approval. May get a CRL. Also, still have to ramp revenue vs. entrenched shot competitors who will claim the shot is safer than the inhaler... Net net little risk to short once the stock reaches $9 a share as the stock has little upside left and lots of downside risks.
Have to wake up early to see how MNKD will trade post this FDA panel vote. Looks like it is likely too late to start trading today in AH. Should open up for trading by 7am eastern time tomorrow morning